Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST003417)

(Analysis AN005616)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11	F12	F13
O-Malonylcarnitine 85	ME896784	0.36	0.31	0.82	0.59	0.35	0.32	1.74	1.25	0.36	0.31	4.69	2.34	0.28
O-Butyrylcarnitine 85	ME896782	1.66	1.85	0.50	0.42	1.53	1.45	0.30	0.21	1.17	1.21	0.19	0.14	1.68
O-Palmitoleoylcarnitine 85	ME896797	1.63	1.87	0.41	0.36	1.42	1.54	0.27	0.24	1.21	1.18	0.18	0.23	1.73
O-Myristoylcarnitine 85	ME896795	1.69	2.16	0.25	0.23	1.48	1.65	0.14	0.14	1.10	1.09	0.08	0.09	1.94
O-Palmitoylcarnitine 85	ME896798	1.71	2.03	0.32	0.33	1.45	1.56	0.17	0.18	1.16	1.25	0.11	0.14	1.80
O-Oleoylcarnitine 85	ME896801	1.38	1.77	0.48	0.64	1.41	1.49	0.39	0.35	1.14	1.31	0.20	0.31	1.56
O-Lauroylcarnitine 85	ME896792	1.50	1.61	0.67	0.35	1.35	1.29	0.59	0.53	1.05	1.14	0.55	0.37	1.49
O-Myristoleoylcarnitine 85	ME896794	1.37	1.44	0.51	0.57	1.26	1.42	0.44	0.57	1.27	1.25	0.30	0.50	1.55
O-Pentadecyloylcarnitine 85	ME896796	1.53	1.60	0.52	0.65	1.30	1.44	0.51	0.45	1.31	1.01	0.54	0.39	1.38
O-Stearoylcarnitine 85	ME896802	1.62	1.54	0.58	0.74	1.36	1.37	0.43	0.56	1.16	1.18	0.34	0.38	1.36
O-Formyl-L-carnitine 85	ME896779	0.85	1.10	0.59	0.36	1.16	1.05	0.69	1.34	1.62	0.70	1.08	1.10	1.18
O-Caprylcarnitine 85	ME896789	1.04	1.49	1.00	0.49	1.28	1.18	0.86	0.93	1.02	0.94	0.71	0.74	1.15
O-Acyl(17:1)carnitine 85	ME896799	1.19	1.45	0.42	0.71	1.41	1.42	0.91	0.73	0.82	1.13	0.81	0.64	1.19
O-Margaroylcarnitine 85	ME896800	1.03	1.56	0.63	0.77	1.43	1.42	0.75	0.64	0.87	1.25	0.58	0.51	1.28
O-Enanthylcarnitine 85	ME896786	0.88	1.09	0.65	1.14	1.40	0.66	1.12	0.69	0.95	0.60	1.36	1.28	1.09
O-Acetylcarnitine 85	ME896780	0.96	0.89	0.97	0.98	0.98	0.84	1.11	0.99	0.92	0.82	1.46	1.31	0.88
O-Caproylcarnitine 85	ME896785	0.98	1.03	0.77	0.84	0.95	0.92	1.08	1.00	1.00	0.98	1.19	1.12	1.07
O-Lauroleoylcarnitine 85	ME896791	1.14	0.87	1.07	1.08	0.73	1.28	0.96	1.14	1.03	0.95	1.09	0.68	0.99
O-Tridecyloylcarnitine 85	ME896793	0.99	0.93	1.05	0.99	1.45	0.80	0.82	0.95	0.98	0.95	1.16	0.56	1.18
O-Pelargonylcarnitine 85	ME896788	0.97	1.18	0.86	1.14	1.03	0.80	1.10	1.14	0.85	1.19	0.64	0.77	1.17
O-Undecyloylcarnitine 85	ME896790	0.87	1.26	1.16	1.08	0.93	0.98	1.10	0.78	1.06	1.04	0.77	0.88	1.05
O-Propionylcarnitine 85	ME896781	0.98	1.17	0.93	0.92	1.05	1.00	0.99	1.03	0.90	1.04	1.05	0.68	1.13
O-Caprylylcarnitine 85	ME896787	0.98	1.06	0.88	1.10	1.11	0.83	0.92	0.91	1.06	0.84	1.03	0.81	1.23
O-Valerylcarnitine 85	ME896783	1.00	1.18	0.86	1.04	1.10	0.90	0.98	0.78	1.20	0.82	0.90	0.98	1.12

Factors:

F1	Sample source:BT-474 Breast cancer cells \| Drug Treatment:1 nM TVB-2640
F2	Sample source:BT-474 Breast cancer cells \| Drug Treatment:1 nM TVB-3166
F3	Sample source:BT-474 Breast cancer cells \| Drug Treatment:200 nM TVB-2640
F4	Sample source:BT-474 Breast cancer cells \| Drug Treatment:200 nM TVB-3166
F5	Sample source:BT-474 Breast cancer cells \| Drug Treatment:20 nM TVB-2640
F6	Sample source:BT-474 Breast cancer cells \| Drug Treatment:20 nM TVB-3166
F7	Sample source:BT-474 Breast cancer cells \| Drug Treatment:500 nM TVB-2640
F8	Sample source:BT-474 Breast cancer cells \| Drug Treatment:500 nM TVB-3166
F9	Sample source:BT-474 Breast cancer cells \| Drug Treatment:50 nM TVB-2640
F10	Sample source:BT-474 Breast cancer cells \| Drug Treatment:50 nM TVB-3166
F11	Sample source:BT-474 Breast cancer cells \| Drug Treatment:5 uM TVB-2640
F12	Sample source:BT-474 Breast cancer cells \| Drug Treatment:5 uM TVB-3166
F13	Sample source:BT-474 Breast cancer cells \| Drug Treatment:Control

Data matrix